A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Insulin (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- Sponsors Hanmi Pharmaceutical
- 31 Aug 2018 Biomarkers information updated
- 07 Nov 2017 Status changed from active, no longer recruiting to completed.
- 09 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.